Tech Company Financing Transactions

ReGen Biologics Funding Round

ReGen Biologics, based in Hackensack, secured $1.7 million from private investors.

Transaction Overview

Company Name
Announced On
2/17/2009
Transaction Type
Venture Equity
Amount
$1,700,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds will support the launch of the Company's Menaflex� collagen meniscus implant device in the U.S., which recently received FDA clearance.

Company Information

Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
411 Hackensack Avenue
Hackensack, NJ 07601
USA
Email Address
Overview
Develops implantable regeneration templates for knee meniscal cartilage.
Profile
ReGen Biologics LinkedIn Company Profile
Social Media
ReGen Biologics Company Twitter Account
Company News
ReGen Biologics News
Facebook
ReGen Biologics on Facebook
YouTube
ReGen Biologics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gerald Bisbee
  Gerald Bisbee LinkedIn Profile  Gerald Bisbee Twitter Account  Gerald Bisbee News  Gerald Bisbee on Facebook
Chief Financial Officer
Brion Umidi
  Brion Umidi LinkedIn Profile  Brion Umidi Twitter Account  Brion Umidi News  Brion Umidi on Facebook
VP - Regulatory Affairs
John Dichiara
  John Dichiara LinkedIn Profile  John Dichiara Twitter Account  John Dichiara News  John Dichiara on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/17/2009: Oasys Water venture capital transaction
Next: 2/17/2009: OpSource venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to record tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary